FIELD: pharmaceuticals.
SUBSTANCE: invention provides CTP-modified human growth hormone polypeptides, pharmaceutical compositions and pharmaceutical compositions containing them, as well as methods of their preparation and use.
EFFECT: obtaining long-acting polypeptides and methods of their production and administration.
30 cl, 39 dwg, 23 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LONG-ACTING POLYPEPTIDES AND METHODS OF THEIR PREPARATION AND ADMINISTRATION | 2014 |
|
RU2746943C2 |
| METHODS FOR PRODUCING CTP-MODIFIED POLYPEPTIDES OF A LONG-ACTING GROWTH HORMONE | 2015 |
|
RU2743295C2 |
| RECOMBINANT CHORIONIC GONADOTROPIN, A METHOD OF ITS PRODUCTION, PHARMACEUTICAL COMPOSITIONS AND THEIR USE | 2019 |
|
RU2803047C1 |
| HIGH GLYCATED FUSED PROTEIN BASED ON HUMAN BLOOD COAGULATION FACTOR VIII, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2016 |
|
RU2722374C1 |
| POLYPEPTIDE CONSTRUCTIONS LYSINE-ANTIMICROBIAL PEPTIDE (AMP), LYSINES, ISOLATED ENCODING POLYNUCLEOTIDES AND VARIANTS OF THEIR APPLICATION | 2019 |
|
RU2803121C2 |
| HUMAN COAGULATION FACTOR FUSED PROTEIN FX (FIX), METHOD FOR PRODUCTION AND USE THEREOF | 2017 |
|
RU2736339C1 |
| COMPOSITE POLYPEPTIDE HAVING METAL-BINDING MOTIF AND MOLECULAR STRUCTURE CONTAINING THEREOF | 2020 |
|
RU2814475C2 |
| IMPROVED IMMUNOGENICITY OF L2 HPV PEPTIDE | 2017 |
|
RU2743016C2 |
| MUCOADHESIVE MICROORGANISM | 2017 |
|
RU2762940C2 |
| COMPOSITIONS AND METHODS FOR EFFECTIVE TARGETING OF TRANSGENES | 2016 |
|
RU2751238C2 |
